AMRX
Amneal Pharmaceuticals, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$19.31
−4.45%Forward multiples
Based on analyst estimates
- P/E forward
- 17.78x
- P/E 2026E
- 19.59x
- P/E 2027E
- 16.73x
- P/E 2028E
- 13.87x
- P/S forward
- 1.87x
Trailing multiples
Trailing twelve months
- P/E TTM
- 38.81x
- PEG TTM
- 0.34x
- Price / book
- 186.73x
- Price / sales
- 1.98x
- Price / cash flow
- 30.71x
Enterprise value
- Enterprise value
- $8.9B
- EV / sales
- 2.86x
- EV / EBITDA
- 13.67x
- EV / EBIT
- 22.11x
- Market cap
- $6.2B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Sep 1, 2026